{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-04-04&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2019-04-04&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-04-04&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&_metadata=all&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-04-04&_page=0&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-04-04&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-04-04&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1109698", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109698/answer", "answerText" : {"_value" : "<p>I refer the hon. Member to the answer given by the former Parliamentary Under-Secretary of State for Public Health and Primary Care (Steve Brine MP) to the hon. Member for South West Bedfordshire (Andrew Selous MP) on 23 January 2019 to Question <a href=\"https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-01-21/210542/\" target=\"_blank\">210542<\/a>.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-04-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-12T11:35:50.96Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Food: Labelling"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the timeframe is for his Department to (a) bring forward legislative proposals on calorie labelling on menus and (b) publish a response to the public consultation on calorie labelling.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
      }
      , "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
      , "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
      ], "uin" : "240990"}
    , {"_about" : "http://data.parliament.uk/resources/1109699", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109699/answer", "answerText" : {"_value" : "<p>This data is not available. Services for people with myalgic encephalomyelitis are commissioned by local clinical commissioning groups. It is the responsibility of the local National Health Service commissioners to ensure NHS services are commissioned to meet local need and that they address any shortfalls in provision. Where appropriate, this will include commissioning services provided by voluntary sector organisations.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-04-12", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "240992"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-12T11:37:15.877Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Chronic Fatigue Syndrome: North East"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much funding the Government has allocated to services used by patients with ME in the North East.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
      }
      , "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
      , "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
      ], "uin" : "240991"}
    , {"_about" : "http://data.parliament.uk/resources/1109700", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109700/answer", "answerText" : {"_value" : "<p>This data is not available. Services for people with myalgic encephalomyelitis are commissioned by local clinical commissioning groups. It is the responsibility of the local National Health Service commissioners to ensure NHS services are commissioned to meet local need and that they address any shortfalls in provision. Where appropriate, this will include commissioning services provided by voluntary sector organisations.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-04-12", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "240991"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-12T11:37:15.937Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Chronic Fatigue Syndrome: North East"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will allocate additional funding to support charities providing direct services to people with ME in the North East.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
      }
      , "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
      , "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
      ], "uin" : "240992"}
    , {"_about" : "http://data.parliament.uk/resources/1109717", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109717/answer", "answerText" : {"_value" : "<p>Leaving the European Union with a \u2018deal\u2019 remains the Government\u2019s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.<\/p><p> <\/p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a \u2018deal\u2019.<\/p><p> <\/p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses \u2018no deal\u2019 contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.<\/p><p> <\/p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a \u2018no deal\u2019 EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).<\/p><p> <\/p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
        }
        , "answeringMemberConstituency" : {"_value" : "Wimbledon"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
        , "dateOfAnswer" : {"_value" : "2019-04-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "241073"}
        , {"_value" : "241074"}
        , {"_value" : "241075"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-09T16:00:30.773Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Bipolar Disorder: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the NHS on the availability of drugs to treat bi-polar disorders in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4523", "label" : {"_value" : "Biography information for Catherine West"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hornsey and Wood Green"}
      , "tablingMemberPrinted" : [{"_value" : "Catherine West"}
      ], "uin" : "241072"}
    , {"_about" : "http://data.parliament.uk/resources/1109718", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109718/answer", "answerText" : {"_value" : "<p>Leaving the European Union with a \u2018deal\u2019 remains the Government\u2019s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.<\/p><p> <\/p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a \u2018deal\u2019.<\/p><p> <\/p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses \u2018no deal\u2019 contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.<\/p><p> <\/p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a \u2018no deal\u2019 EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).<\/p><p> <\/p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
        }
        , "answeringMemberConstituency" : {"_value" : "Wimbledon"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
        , "dateOfAnswer" : {"_value" : "2019-04-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "241072"}
        , {"_value" : "241074"}
        , {"_value" : "241075"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-09T16:00:30.85Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Epilepsy: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the NHS on the availability of drugs to treat epilepsy in the event of that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4523", "label" : {"_value" : "Biography information for Catherine West"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hornsey and Wood Green"}
      , "tablingMemberPrinted" : [{"_value" : "Catherine West"}
      ], "uin" : "241073"}
    , {"_about" : "http://data.parliament.uk/resources/1109719", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109719/answer", "answerText" : {"_value" : "<p>Leaving the European Union with a \u2018deal\u2019 remains the Government\u2019s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.<\/p><p> <\/p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a \u2018deal\u2019.<\/p><p> <\/p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses \u2018no deal\u2019 contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.<\/p><p> <\/p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a \u2018no deal\u2019 EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).<\/p><p> <\/p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
        }
        , "answeringMemberConstituency" : {"_value" : "Wimbledon"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
        , "dateOfAnswer" : {"_value" : "2019-04-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "241072"}
        , {"_value" : "241073"}
        , {"_value" : "241075"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-09T16:00:30.913Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Nervous System: Pain"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the NHS on the availability of drugs to treat neuropathic pain in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4523", "label" : {"_value" : "Biography information for Catherine West"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hornsey and Wood Green"}
      , "tablingMemberPrinted" : [{"_value" : "Catherine West"}
      ], "uin" : "241074"}
    , {"_about" : "http://data.parliament.uk/resources/1109720", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109720/answer", "answerText" : {"_value" : "<p>Leaving the European Union with a \u2018deal\u2019 remains the Government\u2019s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.<\/p><p> <\/p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a \u2018deal\u2019.<\/p><p> <\/p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses \u2018no deal\u2019 contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.<\/p><p> <\/p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a \u2018no deal\u2019 EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).<\/p><p> <\/p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
        }
        , "answeringMemberConstituency" : {"_value" : "Wimbledon"}
        , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
        , "dateOfAnswer" : {"_value" : "2019-04-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "241072"}
        , {"_value" : "241073"}
        , {"_value" : "241074"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-09T16:00:30.977Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, which drugs has his Department identified as at risk of shortage in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4523", "label" : {"_value" : "Biography information for Catherine West"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hornsey and Wood Green"}
      , "tablingMemberPrinted" : [{"_value" : "Catherine West"}
      ], "uin" : "241075"}
    , {"_about" : "http://data.parliament.uk/resources/1109740", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109740/answer", "answerText" : {"_value" : "<p>On 30 January, my Rt, hon. Friend the Secretary of State for Health and Social Care announced that the pre-exposure prophylaxis (PrEP) Impact trial would be expanded. Rollout of additional places on the trial is now commencing. However, participation in the trial is on a voluntary basis for both clinics and local authorities.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-04-12", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "241013"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-12T11:31:52.163Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the additional places on the PrEP Impact Trial are offered across England; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3930", "label" : {"_value" : "Biography information for Caroline Lucas"}
      }
      , "tablingMemberConstituency" : {"_value" : "Brighton, Pavilion"}
      , "tablingMemberPrinted" : [{"_value" : "Caroline Lucas"}
      ], "uin" : "241012"}
    , {"_about" : "http://data.parliament.uk/resources/1109742", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109742/answer", "answerText" : {"_value" : "<p>On 30 January, my Rt, hon. Friend the Secretary of State for Health and Social Care announced that the pre-exposure prophylaxis (PrEP) Impact trial would be expanded. Rollout of additional places on the trial is now commencing. However, participation in the trial is on a voluntary basis for both clinics and local authorities.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-04-12", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "241012"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-12T11:31:52.22Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the NHS England PrEP Impact Trial Update - April 2019, what assessment he has made of the reasons for the finding that 37 councils in England have not provided additional places on the PrEP Impact Trial; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3930", "label" : {"_value" : "Biography information for Caroline Lucas"}
      }
      , "tablingMemberConstituency" : {"_value" : "Brighton, Pavilion"}
      , "tablingMemberPrinted" : [{"_value" : "Caroline Lucas"}
      ], "uin" : "241013"}
    , {"_about" : "http://data.parliament.uk/resources/1109751", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109751/answer", "answerText" : {"_value" : "<p>Our programme of transformation in maternity services will make the National Health Service one of the best places in the world to give birth by supporting maternity services to deliver safer more personalised care for mothers and babies.<\/p><p> <\/p><p>The NHS Long Term Plan built on the progress to implement the findings of the national maternity review set out in \u2018Better Births\u2019 in 2016, and commits us to continue to work with midwives, mothers and their families to implement the \u2018continuity of carer\u2019 recommendation. This will mean that, by March 2021, most women will receive continuity of the person caring for them during pregnancy, during birth and postnatally. Within this, 75% of women from black and minority ethnic groups and disadvantaged communities will have continuity of carer by the end of 2023-24, as the evidence suggests that it particularly improves outcomes for this group.<\/p><p> <\/p><p>We also aim to improve safety by rolling out the Saving Babies\u2019 Lives Care Bundle to every maternity unit in England in 2019. The Bundle supports services in reducing still births, with a new focus on preventing pre-term birth. Every trust in England with a maternity and neonatal service is now part of the National Maternal and Neonatal Health Safety Collaborative, which is supporting practical improvements to make care safer in all maternity units. Through this, we are supporting a culture of multidisciplinary team working and learning, vital for safe, high-quality maternity care. By 2022-23 pre-term birth clinics, Fetal Medicine Services and Maternal Medicine Networks will be rolled out nationally to provide access to more specialist expertise to women, babies and the clinicians caring for them.<\/p><p> <\/p><p>To underpin the improvements to care, the NHS Long Term Plan committed to the digitisation of maternity information so that by 2023-24 all women will be able to access their maternity notes and information through their smart phones or other devices.<\/p><p> <\/p><p>In March 2018, the Department announced plans to train more than 3,000 extra midwives over four years. The Government is providing extra funding for clinical placement costs for 650 students in 2019-20 with planned increases of 1,000 in the subsequent years. The Maternity Workforce Strategy was published in March 2019 by Health Education England to outline how the requirements of Better Births and the ambition to halve stillbirths, neonatal and maternal deaths by 50% by 2025, would be met. This will be achieved through retaining experienced and skilled maternity staff, as well as supporting employers to upskill and develop their workforces through new roles and new ways of working. This includes rolling out the \u2018Maternity Support Worker\u2019 role with a national competency, education and career framework; and new routes to becoming a registered midwife, including via apprenticeships.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
        }
        , "answeringMemberConstituency" : {"_value" : "Thurrock"}
        , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
        , "dateOfAnswer" : {"_value" : "2019-04-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-04-10T15:36:17.513Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Maternity Services"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support maternity services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4593", "label" : {"_value" : "Biography information for Trudy Harrison"}
      }
      , "tablingMemberConstituency" : {"_value" : "Copeland"}
      , "tablingMemberPrinted" : [{"_value" : "Trudy Harrison"}
      ], "uin" : "241079"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-04-04&_page=1&QuestionStatus=Tabled&answeringDeptId=17&max-date=2019-05-20&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "page" : 0, "startIndex" : 1, "totalResults" : 24, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}